Yakang Biotech announced that five parties including Nanjing Laoyan, the company's shareholder, participated in this inquiry and transfer. In the end, 17 investors were allotted at a transfer price of 29.17 yuan/share, and the number of shares transferred was 10,651,781 shares. On September 2, 2026, Mr. Gao Xiang agreed to reduce their holdings by a total of 9.6518 million shares, and the shareholding ratio was reduced from 50.24% to 47.88%.

Yakang Biotech announced that five parties including Nanjing Laoyan, the company's shareholder, participated in this inquiry and transfer. In the end, 17 investors were allotted at a transfer price of 29.17 yuan/share, and the number of shares transferred was 10,651,781 shares. On September 2, 2026, Mr. Gao Xiang agreed to reduce their holdings by a total of 9.6518 million shares, and the shareholding ratio was reduced from 50.24% to 47.88%.